FGH BioTech, Inc.
PrivateLast Round
Early Funding
Apr 12, 2023
Total Funding Raised
$1.18M
Company Overview
FGH BioTech, Inc. is a biopharmaceutical company that develops small-molecule drugs targeting SREBP transcription factors for the treatment of metabolic disorders and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FGH BioTech, Inc. Comparables
Compare FGH BioTech, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sagimet Biosciences | 66% | |
| Dracen Pharmaceuticals, Inc. | 63% | |
| Lime Therapeutics | 62% | |
FGH BioTech, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 12, 2023 |
Key People
Founding team and executive leadership
FGH BioTech, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 12, 2023
Raised $6M in early funding.
FGH BioTech, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FGH BioTech, Inc.'s valuation, stock price, and market status.